Bispecific antibody targeting CD40 and HER2 potentiates therapeutic efficacy by reprogramming macrophages within the tumour microenvironment.
作者信息
Li Na, Li Ruonan, Ma Qiongqiong, Zhang Xiaoqi, Ma Wenxuan, Wang Yi, Duan Baoxin, Yang Kailu, Zhang Dongping, Zhang Jiashuo, Gu Manping, Wu Yaxing, Sun Jiajin, Wang Huawei, Li Anqi, Chen Fuquan, Bai Yiyang, Tian Yujie, Li Xin, Yan Yingbin, Wang Wei, Zhang Hongkai, Wang Yuan
机构信息
Institutes of Biomedical Sciences, School of Life Sciences, Inner Mongolia University, Hohhot, China.
State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University, Tianjin, China.
出版信息
Clin Transl Med. 2025 Aug;15(8):e70428. doi: 10.1002/ctm2.70428.
Abstract
摘要
Zotero 插件